Danish pharmaceutical company Novo Nordisk A/S has raised 4 billion euros ($4.7 billion) through the sale of bonds to finance the acquisition of American biotech company Akero Therapeutics Inc. This ...
A consortium consisting of the Swedish investment company Nordic Capital and the British Permira Holdings Limited refused to take over the Danish biopharmaceutical company Bavarian Nordic A/S for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback